214 related articles for article (PubMed ID: 33674876)
1. Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2.
Bhattacharjee MJ; Lin JJ; Chang CY; Chiou YT; Li TN; Tai CW; Shiu TF; Chen CA; Chou CY; Chakraborty P; Tseng YY; Wang LH; Li WH
Mol Biol Evol; 2021 Jun; 38(7):2715-2731. PubMed ID: 33674876
[TBL] [Abstract][Full Text] [Related]
2. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
[TBL] [Abstract][Full Text] [Related]
3. ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies.
Schmitt CA; Bergey CM; Jasinska AJ; Ramensky V; Burt F; Svardal H; Jorgensen MJ; Freimer NB; Grobler JP; Turner TR
PLoS One; 2020; 15(6):e0235106. PubMed ID: 32574196
[TBL] [Abstract][Full Text] [Related]
4. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
5. In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding.
Bate N; Savva CG; Moody PCE; Brown EA; Evans SE; Ball JK; Schwabe JWR; Sale JE; Brindle NPJ
PLoS Pathog; 2022 Jul; 18(7):e1010733. PubMed ID: 35849637
[TBL] [Abstract][Full Text] [Related]
6. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2.
Castiglione GM; Zhou L; Xu Z; Neiman Z; Hung CF; Duh EJ
PLoS Biol; 2021 Dec; 19(12):e3001510. PubMed ID: 34932561
[TBL] [Abstract][Full Text] [Related]
8. Comparative ACE2 variation and primate COVID-19 risk.
Melin AD; Janiak MC; Marrone F; Arora PS; Higham JP
Commun Biol; 2020 Oct; 3(1):641. PubMed ID: 33110195
[TBL] [Abstract][Full Text] [Related]
9. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847
[TBL] [Abstract][Full Text] [Related]
10. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
12. Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations.
Raghav PK; Raghav A; Lathwal A; Saxena A; Mann Z; Sengar M; Rajalingam R
Sci Rep; 2023 Feb; 13(1):2351. PubMed ID: 36759535
[TBL] [Abstract][Full Text] [Related]
13. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
14. Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution.
Erausquin E; Glaser F; Fernández-Recio J; López-Sagaseta J
Acta Crystallogr D Struct Biol; 2022 Sep; 78(Pt 9):1156-1170. PubMed ID: 36048155
[TBL] [Abstract][Full Text] [Related]
15. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
16. A novel structure-based approach for identification of vertebrate susceptibility to SARS-CoV-2: Implications for future surveillance programmes.
Kaushik R; Kumar N; Zhang KYJ; Srivastava P; Bhatia S; Malik YS
Environ Res; 2022 Sep; 212(Pt C):113303. PubMed ID: 35460633
[TBL] [Abstract][Full Text] [Related]
17. Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants.
Li M; Chen J; Liu Y; Zhao J; Li Y; Hu Y; Chen YQ; Sun L; Shu Y; Feng F; Sun C
Antiviral Res; 2022 Sep; 205():105383. PubMed ID: 35917969
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
[TBL] [Abstract][Full Text] [Related]
19. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
[TBL] [Abstract][Full Text] [Related]
20. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
